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Abstract: Alcoholic fatty liver disease (AFLD) is characterized by an abnormal accumulation of lipid
droplets (LDs) in the liver. Here, we explore the composition of hepatic LDs in a rat model of AFLD.
Five to seven weeks of alcohol consumption led to significant increases in hepatic triglyceride mass,
along with increases in LD number and size. Additionally, hepatic LDs from rats with early alcoholic
liver injury show a decreased ratio of surface phosphatidylcholine (PC) to phosphatidylethanolamine
(PE). This occurred in parallel with an increase in the LD association of perilipin 2, a prominent LD
protein. To determine if changes to the LD phospholipid composition contributed to differences in
protein association with LDs, we constructed liposomes that modeled the LD PC:PE ratios in AFLD
and control rats. Reducing the ratio of PC to PE increased the binding of perilipin 2 to liposomes
in an in vitro experiment. Moreover, we decreased the ratio of LD PC:PE in NIH 3T3 and AML12
cells by culturing these cells in choline-deficient media. We again detected increased association of
specific LD proteins, including perilipin 2. Taken together, our experiments suggest an important
link between LD phospholipids, protein composition, and lipid accumulation.
Keywords: lipid droplets; perilipins; phosphatidylcholine; phosphatidylethanolamine; steatohepatitis

1. Introduction
Fatty liver is an early and consistent morphological feature of alcohol-related liver injury, and with
continued alcohol consumption, can progress to cirrhosis and liver failure [1,2]. The magnitude of this
problem is notable; alcohol-related liver cirrhosis was responsible for nearly 500,000 deaths worldwide
in 2010 [3]. Despite widespread recognition of this significant health problem, the mechanism of how
excessive alcohol consumption results in liver steatosis remains unclear.
With the aim of identifying factors that contribute to fatty liver, we characterized hepatic lipid
droplets (LDs) in a rat model of alcoholic liver injury. LDs are composed of a core of neutral lipids
including triglycerides and cholesteryl esters. The neutral lipid core of an LD is shielded from the
surrounding cytosol by a phospholipid monolayer consisting mostly of phosphatidylcholine (PC)
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and phosphatidylethanolamine (PE) [4,5]. The LD surface is further decorated with LD-associated
proteins, the functions of which vary widely and include roles in lipid metabolism, trafficking,
and signaling [6–8]. Identification of the mechanisms that target LD proteins to the LD surface is
an emerging area of research [9].
Given the intimate relationship between LD proteins and LD function, efforts have been made
to document changes to the LD proteome with the onset of alcohol-induced hepatic steatosis [10,11].
Several studies have reported altered levels of perilipin 2, an abundant and ubiquitously expressed
member of the perilipin protein family. Five major perilipin proteins are known in mammals.
While there are differences in tissue-specific patterns of expression and regulation, perilipin proteins
are widely known to promote lipid storage in LDs [12]. Perilipin 2 correlates with lipid accumulation
in multiple tissues [13] and likely plays an important role in facilitating overaccumulation of lipids
in the liver. Elevated levels of perilipin 2 have been detected in both human liver biopsies [14] and
animal models of alcoholic fatty liver disease (AFLD) [15–18]. In addition, the absence of perilipin 2 in
mice prevents alcohol-induced [19] or diet-induced [20] hepatic steatosis.
Significant changes to the lipid composition of hepatocytes have been observed during the
development of steatosis. Fernando et al. reported differences in the levels of hepatic cholesterol,
triglycerides, and phospholipids that distinguish alcohol-fed rats from paired control animals [21].
We and others have detected a decrease in hepatic PC levels following alcohol ingestion [22–24].
Studies from our laboratory have implicated alcohol in the alteration of the methionine metabolic
pathway [25,26] and the consequent lowering of the ratio of hepatic S-adenosylmethionine (SAM) to
S-adenosylhomocysteine (SAH) [23]. The decrease in this ratio is known to inhibit the activities of many
methyltransferases [25,26] including phosphatidylethanolamine methyltransferase (PEMT) [23,27].
Because PEMT catalyzes the three successive methyl group transfers from SAM to PE to generate
PC [28], inhibition of this enzyme decreases PC synthesis.
In this study, we found significant differences in the overall composition of hepatic LDs from
control and ethanol-fed rats. Relative amounts of PC and PE, along with association of specific
LD proteins, were altered in hepatic LDs from ethanol-fed rats. We modeled the changes to the
phospholipid composition of LDs in cultured cells and in vitro experiments and detected similar
changes in the association of specific LD proteins. Therefore, we propose that changes to the LD
phospholipid composition impact protein association and LD function.
2. Materials and Methods
2.1. Diet Formulation
Nutritionally adequate Lieber–DeCarli control and ethanol liquid diets [29] were purchased from
Dyets, Inc. (Bethlehem, Palestine). The ethanol diet consisted of 18% total energy as protein, 35% as
fat, 11% as carbohydrate, and 36% as ethanol. In the control diet, ethanol was replaced isocalorically
with carbohydrate such that both ethanol and control rats consumed identical amounts of all nutrients
except carbohydrate.
2.2. Ethanol Feeding Procedure
Male Wistar rats (Charles River Laboratories, Wilmington, MA, USA) weighing 180–200 g
(approximately 45–48-days old) were weight-matched and divided into two groups. Group 1 was
fed the control diet and group 2 was fed the ethanol diet. The rats were pair-fed in that the group
1 rats were fed the amount of diet consumed by the rats in group 2 on the previous day. Overall,
each group consisted of eight rats fed the appropriate diet for 5–7 weeks. Twenty-four hours before
sacrifice, the total daily volume of the diet was divided with one-fourth given at 8:00 am, one-fourth at
12:00 pm, and one-half at 4:00 pm. In addition, animals were given one-fourth of their respective diets
60–90 min prior to sacrifice. This regimen was followed to minimize differences in feeding patterns
that exist between the groups of rats. The care, use, and procedures performed were approved by
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the Institutional Animal Care and Use Committee of the Omaha Veterans Affairs Medical Center
and were in accordance with the Public Health Service (PHS) Policy on Human Care and Use of
Laboratory Animals.
2.3. Histological Analysis of LD Number and Size
Tissues were frozen in optimum cutting temperature compound (Tissue-TeK, Torrance, CA, USA).
Fresh cut sections (5 µm) were fixed in 4% w/v paraformaldehyde in 50 mM PIPES, pH 7.0, and the
accumulated lipid was visualized by staining with 1 µg/mL BODIPY 493/503 (Invitrogen, Carlsbad,
CA, USA). After incubation, slides were washed twice with PBS and mounted with Vectashield/DAPI
(Vector laboratories, Burlingame, CA, USA). Images were obtained with a Zeiss 510 Meta Confocal
Laser Scanning Microscope using an excitation wavelength of 488 nm and an emission wavelength of
505 nm. Quantification of LD number and size was carried out using ImageJ software (NIH, Bethesda,
MD, USA). For quantification, three different fields were randomly selected from each section and data
were pooled from sections obtained from three different sets of control and ethanol-fed animal pairs.
2.4. Lipolysis
Isolated hepatocytes were plated on collagen-IV-coated dishes using Williams’ E medium
supplemented with antibiotics and 5% FCS. After 2 h of plating, the growth medium was replaced
with Williams’s E without serum medium supplemented with 50 µM oleic acid complexed to 0.4% BSA
containing [3 H]-oleic acid (1 × 106 dpm/dish) as a tracer to label cellular triglycerides. To examine
cellular lipolysis, the efflux of free [3 H]-oleic acid was tracked over 6 h in the presence of 10 µM triacsin
C (Biomol, Plymouth Meeting, PA, USA), an inhibitor of acylcoenzyme A synthetase in the medium
that prevents re-esterification of fatty acids.
2.5. Isolation of LDs from Rat Livers
LDs were isolated from rat liver as described previously [18]. Briefly, 20% liver homogenate
was prepared in 60% sucrose in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.4) containing 1 mM
PMSF and protease inhibitor cocktail. A postnuclear supernatant (PNS) fraction was obtained by
centrifugation (1000 × g) of the homogenate for 10 min. LDs were isolated by subjecting the obtained
PNS to ultracentrifugation through prechilled discontinuous gradient of sucrose solutions (40%, 25%,
and 10%) in TE buffer. The tubes were centrifuged (30,000 × g) in a precooled SW28 rotor in a Beckman
L-70 ultracentrifuge at 4 ◦ C for 30 min with slow acceleration and no brake. The white band (LD
fraction) at the top of the gradient was collected and further purified by centrifugation (20,800 × g) for
10 min. The clear buffer underlying the white band was removed and the LD fraction diluted to 200 µL
with TE buffer and frozen at −70 ◦ C. The total volume of reconstitution buffer remained constant/gm
liver used for homogenization.
2.6. SDS-PAGE and Immunoblotting of Proteins from Rat Livers
Western blotting was performed as described previously [23,30]. Briefly, LD samples (diluted
1:4) were resolved on 12% SDS-PAGE under reducing conditions and transferred onto nitrocellulose
membranes. The blots were blocked for 1 h at 37 ◦ C with PBS, pH 7.4, 0.05% Tween-20 (PBS-T)
containing 5% nonfat dry milk and then incubated overnight with primary antibodies at 4 ◦ C.
Anti-Perilipin 2 (cat# 10R-A117ax; Fitzgerald, Acton, MA, USA) and Anti-Perilipin 3 (cat# ab77365;
Abcam Inc., Cambridge, MA, USA) were used at a 1:20,000 and 1:2,000 dilution, respectively.
After incubation with the primary antibodies, the membranes were washed 3 times for 5 min each
with PBS-T and then incubated with peroxidase-conjugated secondary antibody for 1 h at room
temperature. Blots were extensively washed with PBS-T, washed once with PBS, and the proteins were
visualized using standard ECL detection methods. The intensities of immunoreactive protein bands
were quantified using Quantity One software (Bio-Rad Laboratories, Hercules, CA, USA).
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2.7. Lipid Analysis from Rat Livers
Lipids were extracted from liver tissue, or isolated hepatic LDs, using the Folch procedure [31].
The total triglyceride content from these samples was determined as detailed in [23]. In addition, the
lipid residue was dissolved in chloroform and applied (along with appropriate standards) to a Silica
gel G-plate (Uniplate, Analtech Inc., Newark, DE, USA) to separate PC and PE by TLC using n-propyl
alcohol/propionic acid/chloroform/water (2:2:2:1) as solvent [32]. The spots corresponding to PC
and PE, verified by standards run on the same plate, were visualized by spraying with Molybdenum
Blue (Sigma-Aldrich, St. Louis, MO, USA), followed by scraping and subsequent analysis for total
phosphorous [33] to quantify the level of PC and PE.
2.8. Hepatic S-adenosylmethionine-to-S-adenosylhomocysteine (SAM:SAH) Ratio
High-performance liquid chromatography (HPLC) analysis was performed on the perchloric acid
extract of total liver for determining SAM and SAH levels as detailed previously [21] to calculate the
SAM:SAH ratio.
2.9. In Vitro Binding Assay
Perilipin 2 association with large unilamellar vesicles (LUVs) of varied phospholipid composition
was performed as previously described [34]. Briefly, a total of 12 µmols of dioleoyl-PC and dioleoyl-PE
(Avanti Polar Lipids) at ratios of 4.5:1, 3.5:1, 2.5:1, and 1.5:1 were dried under vacuum. Samples were
warmed to 70 ◦ C and 1 mL of Hepes/EDTA buffer (10 mM Hepes, 5 mM EDTA, pH 7.4) was added to
each. Lipid films were hydrated on a rocking platform at 50◦ C. LUVs were formed by five cycles of
freeze/thaw in a dry ice and ethanol bath.
The cytosol from perilipin-2-expressing HEK293 cells provided a source of partially purified
perilipin 2 [34]. While perilipin 2 efficiently targets to LDs in this cell line, a significant pool of
undegraded protein remains in the cytosol [35]. Perilipin-2-expressing HEK293 cells were pelleted and
resuspended in Hepes/EDTA buffer with protease inhibitors (1 µg/mL pepstatin, 1 µg/mL leupeptin,
100 µg/mL PMSF), then homogenized and lysed with a 25-g needle. Lysed cells were adjusted to
10% sucrose then loaded in a centrifuge tube and overlaid with Hepes/EDTA buffer. Samples were
centrifuged at 280,000 × g at 4 ◦ C for 3 h. Perilipin-2-enriched cytosol was collected from the void
volume, combined with the LUVs, and incubated in an orbital mixer at room temperature for 1 h.
Samples were adjusted to 25% sucrose, loaded into a centrifuge tube, overlaid with 15% sucrose in
Hepes/EDTA buffer, and centrifuged at 280,000 × g at 4 ◦ C for a minimum of 3 h. Floating LUVs
were collected with a 22-g needle. As floating fractions were visibly turbid, we used a Nanodrop
2000 spectrophotometer to compare concentrations of collected LUVs and diluted samples when
necessary to achieve overlapping spectra. Perilipin 2 was detected in floating fractions of equivalent
concentrations by SDS-PAGE and immunoblotting.
2.10. Cell Culture
NIH 3T3 mouse fibroblasts, provided by Sabrice Guerrier (Millsaps College, Jackson, MS, USA)
or obtained from ATCC, were cultured in DMEM (Gibco, #11965) supplemented with 10% bovine
calf serum (Fisher, 41400-045, Hampton, NH, USA) and 1% penicillin/streptomycin (Gibco). AML12
cells, derived from mouse hepatocytes, were provided by Doug Mashek (University of Minnesota,
Twin Cities, MS, USA) and cultured in DMEM supplemented with 10% FBS (Atlanta Biologicals,
Atlanta, GA, USA), 1% penicillin/streptomycin, and 0.1% insulin-transferrin-selenium (Fisher,
41400-045, Hampton, NH, USA). For choline depletion, media was prepared with choline-deficient
DMEM (a modification of Gibco #11965 formulated without choline chloride). Where indicated, media
was additionally supplemented with 500 µM oleate complexed with BSA as described [36].
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2.11. Isolation of LDs from Cultured Cells
NIH 3T3 and AML12 cells were cultured with 500 µM oleate with or without choline for 48 h.
The cells were washed and scraped into cold PBS, pelleted, and resuspended in Hepes/EDTA buffer
with protease inhibitors. Cell suspensions were incubated on ice for 10 min and lysed by multiple
passages through a 25-g needle. Cell lysates were overlaid with Hepes/EDTA buffer and centrifuged
at 275,000 × g at 4 ◦ C for at least 30 min. Floating LDs were transferred to a second centrifuge tube,
adjusted to 25% sucrose, overlaid with Hepes/EDTA buffer and centrifuged at 275,000 × g at 4 ◦ C
for at least 30 min. Floating LDs were collected and spun in a microcentrifuge for 20 min at 4 ◦ C.
Removal of the infranatant increased the concentration of the LD samples. Total protein levels in each
LD sample were determined with the Bradford protein assay [37]. Phosphate levels were determined
using the method of Ames and Dubin [38].
To measure PC and PE content of isolated LDs, lipids were extracted as described by Bligh and
Dyer [39]. Lipids were separated on silica plates (Analtech) with chloroform:methanol:25% ammonia
(50:25:6) and visualized with iodine vapor. PC and PE bands from the lipid extract were identified
by comparison to standards (Avanti Polar Lipids). The pixel intensity of each band was determined
with ImageJ.
2.12. SDS-PAGE and Immunoblotting of Proteins from Cultured Cells
Equivalent amounts of LUVs or total LD associated proteins were resolved on 10% SDS-PAGE
gels. Proteins were transferred to nitrocellulose membrane and resolved with rabbit polyclonal
antibodies to perilipin 2 (Novus Biologicals) or perilipin 3 (Nathan E. Wolins, Washington University,
St. Louis, MO, USA) and peroxidase-conjugated secondary antibodies (Sigma). Bands were
visualized with Supersignal West Femto ECL reagent (Fisher) and a FotoDyne FOTO/Analyst
Luminary/FX workstation.
3. Results
3.1. Effect of Ethanol on Liver Phenotype
Five to seven weeks on an ethanol-enriched Lieber–DeCarli diet led to dramatic increases in
hepatic lipid accumulation in male Wistar rats (Figure 1A). Measurements of BODIPY-stained LDs
in frozen liver sections from control and ethanol-fed rats demonstrated an increase in both LD size
(Figure 1B) and number (Figure 1C). We also detected differences in hepatic lipid metabolism following
ethanol feeding. Hepatocytes isolated from ethanol-fed rats displayed a decrease in the rate of
lipolysis (Figure 2A). Since up to 70% of the triglycerides packaged and secreted by hepatocytes in
very-low-density lipoproteins (VLDLs) are derived via lipolysis of preformed triglyceride stores in
LDs [40–42], the approximate 50% reduction in lipolysis observed in this study is consistent with our
previous report showing a decreased in vivo VLDL secretion rate in the ethanol-fed rats compared to
control rats [43].
Triacylglycerol hydrolase (TGH) is a major lipase in hepatocytes that has been shown to mobilize
LD triglycerides for VLDL assembly [44–46]. Thus, we hypothesized that the ethanol-induced
reduction in lipolysis may be a consequence of reduced hepatic TGH activity in these rats. However,
we observed no difference in hepatic TGH activity between control and ethanol-fed animals (Figure 2B).
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Figure 1. Male Wistar rats on an ethanol-enriched Lieber–DeCarli diet develop fatty liver. (A)
Confocal images of representative liver sections stained with BODIPY (green, LDs) and DAPI (blue,
nuclei). (B, C) Chronic ethanol exposure increased the diameter and number of hepatic LDs. Values
are mean ± SEM from nine fields of view of liver sections from five control and five ethanol-fed
animals. Data were analyzed by ANOVA followed by Tukey’s test for specific comparisons between
means (*, p < 0.05).
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Triacylglycerol hydrolase (TGH) is a major lipase in hepatocytes that has been shown to mobilize
LD triglycerides for VLDL assembly [44–46]. Thus, we hypothesized that the ethanol-induced
reduction in lipolysis may be a consequence of reduced hepatic TGH activity in these rats. However,
we observed no difference in hepatic TGH activity between control and ethanol-fed animals (Figure
2B).

Figure 2. Chronic ethanol exposure decreased lipolysis from isolated hepatocytes. (A) The efflux
of radiolabeled oleic acid from hepatocytes isolated from control or ethanol-fed rats. Values are
mean ± SEM (*, p < 0.05; n = 5). (B) Triacylglycerol hydrolase (TGH) activity in microsomal and lipid
droplet (LD) fractions.
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3.3. In Vitro Analysis of Perilipin 2 Binding

Many organelles use special lipids (e.g., phosphoinositides, phosphatidylserine, phosphatidic
acid) for mediating protein targeting to membranes [47,48]. Whether LDs utilize such a strategy for
recruiting surface proteins is unknown. Since the phospholipid ratio (PC and PE) and surface protein
association (perilipins 2 and 3) in hepatic LDs are both altered by ethanol exposure, we considered the
possibility that these major LD surface phospholipids played a role to recruit LD proteins. To test this
conjecture, we utilized an in vitro binding assay previously developed to explore perilipin 2 targeting
to lipid droplet surfaces [34].
The in vitro binding assay requires a large amount of soluble protein. This is difficult as LD
proteins, including the perilipin family members, frequently precipitate upon purification [49].
To circumvent this problem, we used the cytosol from a perilipin 2 overexpresssing cell line as
a source of soluble protein [35]. We have previously shown that perilipin 2 from this cytosolic
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fraction can bind to large LUVs and that this interaction depends on the acyl chain composition of the
surface phospholipids. Here, we extended that work to determine if the headgroups of the surface
also influenced perilipin 2 binding.
Cells 2018, 7,phospholipids
x
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Figure 4. Chronic ethanol exposure alters the protein composition of hepatic LDs. Levels of perilipin
Figure 4. Chronic ethanol exposure alters the protein composition of hepatic LDs. Levels of perilipin
2 (A,C) and perilipin 3 (B,D) in equivalent amounts (per gram) of liver tissue were determined by
2 (A, C) and perilipin 3 (B, D) in equivalent amounts (per gram) of liver tissue were determined by
SDS-PAGE and Western blotting. (A,B) Representative Western blots from control (−) or ethanol (+)
SDS-PAGE and Western blotting. (A-B) Representative Western blots from control (−) or ethanol (+)
treated rats are shown. (C,D) Summary data are average values relative to the control ± SEM from
treated rats are shown. (C, D) Summary data are average values relative to the control ± SEM from
five experiments. Asterisks indicate values for ethanol-treated rats are statistically different than 1.0
five experiments. Asterisks indicate values for ethanol-treated rats are statistically different than 1.0
(*, p < 0.04, Wilcoxon signed-rank test).
(*, p < 0.04, Wilcoxon signed-rank test).
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targeting to lipid droplet surfaces [34].
The in vitro binding assay requires a large amount of soluble protein. This is difficult as LD
proteins, including the perilipin family members, frequently precipitate upon purification [49]. To
circumvent this problem, we used the cytosol from a perilipin 2 overexpresssing cell line as a source
of soluble protein [35]. We have previously shown that perilipin 2 from this cytosolic fraction can
bind to large LUVs and that this interaction depends on the acyl chain composition of the surface
phospholipids. Here, we extended that work to determine if the headgroups of the surface
phospholipids also influenced perilipin 2 binding.
We constructed LUVs that mimicked the PC:PE ratios observed in the livers of control and
ethanol-fed rats and incubated the LUVs with perilipin 2 from the cytosolic fraction of perilipin 2
overexpressing HEK 293 cells [35] as previously described [34]. Next, unbound perilipin 2 was
separated from the LUVs by sucrose gradient centrifugation. We compared the amount of perilipin 2
that fractionated with the LUVs of each phospholipid composition (Figure 5). These experiments
showed that the relative levels of PC and PE influenced the amount of perilipin 2 bound to LUVs.
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in LUV fractions was quantified. Data are expressed relative to the PC:PE ratio detected in hepatic
LDs from control animals (3.5:1) and are mean values ± SEM from six to seven experiments. (*, p <
0.02, Wilcoxon signed-rank test).
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3.4. Manipulation of LD Phospholipid Levels in Cultured Cells
Our in vitro experiments support the hypothesis that the relative levels of PC and PE influence
perilipin 2 binding. We sought to further explore the relationship between LD phospholipid ratios and
associated protein levels in a cell culture system where we could manipulate LD composition while
maintaining the complexity of in vivo LD form and function. We chose to manipulate phospholipid
levels directly rather than induce changes through ethanol supplementation. With this approach,
we aimed to confirm that decreasing PC content relative to PE in the LD surface monolayer would
be able to influence LD protein composition on its own, independent of other factors generated by
ethanol consumption.
We altered the relative amount of PC and PE on LDs in cultured NIH 3T3 fibroblasts by
diminishing the amount of available choline. In most tissues, over 70% of PC is synthesized directly
from choline via the Kennedy pathway and up to 95% of available choline is used in this synthesis
of PC [50]. We therefore hypothesized that culturing cells in choline-deficient media for 48 h would
decrease intracellular PC through elimination of the primary precursor. Moreover, we hypothesized
that the decrease in intracellular PC would alter phospholipid surfaces throughout the cell, including
the LD surface. To test this strategy, LDs were isolated from control and choline-deficient NIH 3T3
cells and the phospholipid components were separated by thin layer chromatography and quantified.
LDs from choline-deficient NIH 3T3 cells had less LD-associated PC relative to PE when compared
with LDs from control cells (Figure 6A). We used a similar approach to attempt to alter phospholipid
levels in AML12 cells, a mouse hepatocyte cell line. AML12 cells also showed decreased PC relative to
PE Cells
on LDs
48 h in choline-deficient media (Figure 6B). Thus, choline depletion is an effective
2018,following
7, x
10 of 15
general strategy for altering the phospholipid composition of LDs in cultured cells.

Figure 6. Choline deficiency significantly reduces the PC:PE ratio of LD phospholipid monolayers.
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We used SDS-PAGE and Western blotting of LD proteins from control and choline-deficient cells
to look specifically at LD association of perilipin 2 and 3, proteins that were abundant in hepatic LDs
from the ethanol-fed rats. Our results indicated a 1.5-fold increase in perilipin 3 association with LDs
in choline-deficient NIH 3T3 cells (Figure 7C). We also detected a 1.4-fold increase in association of
perilipin 2 with LDs from choline-depleted NIH 3T3 cells compared to LDs of control cells (Figure
7D). Similar experiments in choline-deficient AML12 cells also demonstrated an increase in LDassociated perilipin 2 (Figure 7E). These results provide support to the hypothesis that decreasing the
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We used SDS-PAGE and Western blotting of LD proteins from control and choline-deficient cells
to look specifically at LD association of perilipin 2 and 3, proteins that were abundant in hepatic LDs
from the ethanol-fed rats. Our results indicated a 1.5-fold increase in perilipin 3 association with LDs
in choline-deficient NIH 3T3 cells (Figure 7C). We also detected a 1.4-fold increase in association of
perilipin 2 with LDs from choline-depleted NIH 3T3 cells compared to LDs of control cells (Figure 7D).
Similar experiments in choline-deficient AML12 cells also demonstrated an increase in LD-associated
perilipin 2 (Figure 7E). These results provide support to the hypothesis that decreasing the amount of
LD PC relative to PE alters LD association of specific proteins.
4. Discussion
Analysis of LDs in a rat model of AFLD provides new information about the progression of
this disease. Rats on an ethanol-enriched diet for 5–7 weeks had a massive overaccumulation of
hepatic LDs with lower levels of lipolysis. The decrease in lipolysis likely negatively impacted
VLDL secretion, as was previously reported [43]. The hepatic LDs from ethanol-fed rats showed
differences in phospholipid and protein composition when compared with LDs isolated from control
animals. Specifically, hepatic LDs from ethanol-fed rats showed a decrease in the PC:PE ratio of surface
phospholipids compared to controls. We believe that the changes to phospholipid levels were caused
by our previously reported impairment in PEMT activity [23,27]. Inhibition of PEMT likely occurs in
response to ethanol-induced elevation of hepatocellular SAH and a reduction in the SAM:SAH ratio.
Our data support a model where the relative amounts of PC and PE on the surface of LDs impact
the association of specific LD proteins. We detected more perilipin 2 and 3 in LD fractions from
ethanol-fed animals where phospholipid levels were also changed. However, because hepatocytes
from ethanol-fed rats also had an elevated number of LDs, we cannot definitively attribute the higher
levels of perilipin 2 and 3 to the altered phospholipid content of LDs. Instead, we sought an alternate
approach to determine the effect of changes in LD phospholipid levels. Notably, while the total
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level of LD protein was not changed, we measured an increase in perilipin 2 and 3 on LDs in NIH
3T3 and AML12 cells cultured under conditions that altered LD phospholipid levels. Moreover,
we demonstrated a direct link between PC:PE composition and perilipin 2 binding in an in vitro assay
that detected protein association with phospholipid vesicles. Both of these results suggest that changes
to LD surface properties impact protein binding.
Evidence is emerging that the unique biophysical properties of the LD surface facilitate localization
of LD proteins. Some LD proteins likely access the LD from the endoplasmic reticulum; others are
translated in the cytosol and associate with LDs via amphipathic alpha helices or other hydrophobic
domains [9]. Proteins that localize to LDs through amphipathic alpha helices may rely on “packing
defects” at the LD surface to assist in association and folding [51]. Packing defects describe areas of the
LD surface where the underlying hydrocarbons of the phospholipid acyl chains or core neutral lipids
are exposed to the surrounding aqueous environment. Two recent reports describe the prevalence of
packing defects at the LD surface [51,52]. Our previous experiments suggest that perilipin 2 localizes to
LDs through a mechanism involving LD surface packing defects [34]. We demonstrated that perilipin
2 association with lipid vesicles was disrupted by increasing the proportion of surface phospholipids
with saturated acyl chains, a change that also increased surface lipid packing and likely decreased
access to the underlying hydrophobic lipids.
In this paper, we identify changes to the PC:PE composition of the LD surface. We hypothesize
that this change in LD surface composition also increases LD surface packing defects. PC is a
cylindrical phospholipid and as such may form a surface that shields underlying hydrophobic lipid
from interacting with surface proteins. On the other hand, the smaller headgroup of PE may allow
additional interactions between surface proteins and hydrophobic lipids. Proteins like perilipin 2
and 3, that interact with LDs through amphipathic helical domains [53], may associate more readily
with a surface enriched for PE rather than PC as there would be more opportunity for interaction
between the hydrophobic amino acid side chains and underlying hydrophobic lipid. This work is
therefore consistent with the model shared by Prevost and Sharp et al., whereby packing defects in the
phospholipid monolayer at the LD surface assist in the association and folding of amphipathic alpha
helical domains of LD proteins [51].
There is ample evidence linking perilipin family proteins to LD growth [12]. Perilipin 2 association
with LDs has been shown to promote LD accumulation [54–58] by reducing triglyceride turnover [35],
and perilipin 2 knockout mice are protected from hepatic steatosis [19,20]. Thus, changes to the amount
of perilipin 2 on LDs may directly contribute to the growth and accumulation of hepatic LDs. Ongoing
experiments in our laboratory aim to identify additional proteins that preferentially bind LDs enriched
for PC and could contribute to LD accumulation. Perilipin 5 is a candidate protein given its sequence
similarity to perilipin 2. Perilipin 5 expression is elevated with hepatic steatosis and its ablation
decreases lipid accumulation in the liver [59].
Changes in phospholipid composition may impact LD size and number through pathways that
do not involve altering the LD proteome. For example, LDs that lack sufficient PC to shield underlying
hydrophobic lipids fuse, thereby creating super-sized LDs [60,61]. Moreover, blocking PC synthesis
promotes lipid droplet accumulation through SREBP-1-dependent gene transcription [62]. The relative
contribution of each of these pathways is unknown but the end result is clear; a change to the relative
amount of phosphatidylcholine on LDs appears to promote LD growth.
Our rat model of AFLD shows some similarities to other models of pathophysiological changes
to hepatic lipid metabolism. A choline-deficient diet is widely used to promote liver steatosis in
animal models, whereas choline supplementation reverses the liver steatosis observed in rats on a
high-fat diet [63]. A decrease in hepatic PC relative to PE also correlates with the development of
hepatic steatosis in a mouse model of nonalcoholic fatty liver disease [64]. Collectively, these studies
further support a link between changes to LD phospholipid levels and overaccumulation of LDs in
animal models.
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The link between LD surface content and LD growth and accumulation is further supported by
several studies in cultured cells. Knockdown of enzymes involved in PC biosynthesis leads to the
formation of large LDs in Drosophila S2 cells and murine bone-marrow-derived macrophages [60,61].
Horl et al. demonstrated a significant decrease in the ratio of PC to PE on LDs during differentiation
of 3T3-L1 adipocytes [65]. Moreover, inhibition of PC synthesis in this cell line by suppression of
PEMT expression increased lipid accumulation, decreased basal lipolysis, and led to a decrease in LD
association of perilipin A, the predominant perilipin protein in adipocytes. This work suggests that
the correlation between LD phospholipid content and LD accumulation is not specific to the cell types
included in this study but plays a more basic role in lipid accumulation in multiple tissues.
As a dynamic organelle, the composition of an LD responds to changing nutrient and hormone
levels [66,67]. Our work suggests that specific changes to the phospholipid composition of hepatic LDs
can impact its function by modifying the association of specific LD proteins, which in turn affects the
breakdown of the LD triglyceride stores, the rate of formation and secretion of VLDL, and, ultimately,
lipid accumulation. Therefore, careful examination of features of the LD surface and, more specifically,
the way in which LD composition changes under pathophysiological conditions may contribute to our
understanding of multiple diseases that involve overaccumulation of lipid droplets including AFLD
and nonalcoholic fatty liver disease.
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